EBQ:Transfusion strategies for acute upper gastrointestinal bleeding: Difference between revisions

No edit summary
(new article)
Line 16: Line 16:


==Clinical Question==
==Clinical Question==
*Is a restrictive transfusion strategy superior to a liberal transfusion strategy in patients with upper GI bleeds?


==Conclusion==
==Conclusion==
*Lower mortality in the restrictive transfusion group (hemoglobin threshold 7) 5% vs 9% (p=0.02)
 


==Major Points==  
==Major Points==  
*Transfusion threshold of hemoglobin 7g/deciliter if hemodynamically stable
*Study excluded unstable patients


==Inclusion Criteria==  
==Inclusion Criteria==  
*Age >18
*Melena or hematemasis
*Consent to blood transfusion


==Exclusion Criteria==
==Exclusion Criteria==
*Massive GI bleed
*Lower GI bleeding
*ACS
*Stroke/TIA
*Symptomatic PVD
*Transfusion in the previous 90 days
*Recent trauma or surgery
*Decision by attending physician that patient should not get a specific therapy
*Rockall score (assessment of future bleeding risk) of 0 with hemoglobin > 12


==Interventions==  
==Interventions==  
*Transfusion threshold set at hgb 7 with target range 7-9 vs hgb 9 with target range 9-11




==Outcome==
==Outcome==
*Lower mortality with restrictive transfusion strategy 5% vs 9% (p=0.02)


===Primary Outcomes===
===Primary Outcomes===
*Death from any cause in the first 45 days
**Lower with restrictive strategy


===Secondary Outcomes===  
===Secondary Outcomes===  
*Rate of in hospital hematemasis or melena with hemodynamic instability
*2 point fall in hemoglobin in 6 hours
*Number of patients requiring transfusion in each group
   
   


===Subgroup analysis===
===Subgroup analysis===
*Cirrhotic patients
**Lower mortality with restrictive strategy in Child's class A and B
**No difference in Child's class C
**No significant difference when all cirrhotics taken as a group
*Peptic ulcer disease
**No significant difference
   
   


==Criticisms==
==Criticisms==
*1 unit of pRBCs was transfused up front in both groups. Therefore, there was no true conservative transfusion group. The study suggests that a transfusion threshold of hgb 7 is superior, but cannot definitively answer the question as all patients in the study received a transfusion.
 
*All patients received an EGD within 6 hours. This may not be always be achievable. The study findings may not be generalizable.
*Massive GI bleeds, which were excluded from the trial, are not defined


==Funding==
==Funding==
*No external funding


==Sources==
==Sources==

Revision as of 04:35, 26 March 2014

incomplete Journal Club Article
Villanueva C. et al. "Transfusion strategies for acute upper gastrointestinal bleeding". NEJM. 2013. 368(1):11-21.
PubMed Full text PDF

Clinical Question

  • Is a restrictive transfusion strategy superior to a liberal transfusion strategy in patients with upper GI bleeds?

Conclusion

  • Lower mortality in the restrictive transfusion group (hemoglobin threshold 7) 5% vs 9% (p=0.02)


Major Points

  • Transfusion threshold of hemoglobin 7g/deciliter if hemodynamically stable
  • Study excluded unstable patients

Inclusion Criteria

  • Age >18
  • Melena or hematemasis
  • Consent to blood transfusion

Exclusion Criteria

  • Massive GI bleed
  • Lower GI bleeding
  • ACS
  • Stroke/TIA
  • Symptomatic PVD
  • Transfusion in the previous 90 days
  • Recent trauma or surgery
  • Decision by attending physician that patient should not get a specific therapy
  • Rockall score (assessment of future bleeding risk) of 0 with hemoglobin > 12

Interventions

  • Transfusion threshold set at hgb 7 with target range 7-9 vs hgb 9 with target range 9-11


Outcome

  • Lower mortality with restrictive transfusion strategy 5% vs 9% (p=0.02)

Primary Outcomes

  • Death from any cause in the first 45 days
    • Lower with restrictive strategy

Secondary Outcomes

  • Rate of in hospital hematemasis or melena with hemodynamic instability
  • 2 point fall in hemoglobin in 6 hours
  • Number of patients requiring transfusion in each group


Subgroup analysis

  • Cirrhotic patients
    • Lower mortality with restrictive strategy in Child's class A and B
    • No difference in Child's class C
    • No significant difference when all cirrhotics taken as a group
  • Peptic ulcer disease
    • No significant difference


Criticisms

  • 1 unit of pRBCs was transfused up front in both groups. Therefore, there was no true conservative transfusion group. The study suggests that a transfusion threshold of hgb 7 is superior, but cannot definitively answer the question as all patients in the study received a transfusion.
  • All patients received an EGD within 6 hours. This may not be always be achievable. The study findings may not be generalizable.
  • Massive GI bleeds, which were excluded from the trial, are not defined

Funding

  • No external funding

Sources